Exercise program aims to boost strength before stem cell transplant

NCT ID NCT06280924

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 10-week tailored exercise program, done in-person or online, can help multiple myeloma patients maintain physical fitness, muscle mass, and quality of life while undergoing chemotherapy before a stem cell transplant. Researchers will enroll 30 adults in Alberta to see if patients are willing and able to participate. The main goal is to measure how many people complete the program, not to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tailored exercise program (prehabilitation)
What this could lead to
If successful, this could show that a flexible exercise program helps multiple myeloma patients stay stronger and feel better while waiting for a stem cell transplant.
What could go wrong
This is a small feasibility study with only 30 participants, so results may not apply to everyone. The main goal is to see if patients can stick with the program, not to prove it works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXERCISE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Alberta/ Cross Cancer Institute

    RECRUITING

    Edmonton, Alberta, T6G 2G4, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.